+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Does cholesterol lowering induce retardation of progression or even regression of coronary artery disease? a meta analysis of the angiographic coronary regression trials



Does cholesterol lowering induce retardation of progression or even regression of coronary artery disease? a meta analysis of the angiographic coronary regression trials



European Heart Journal 13(ABSTR Suppl.): 161




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030993054

Download citation: RISBibTeXText


Related references

Management of high cholesterol in patients with a history of coronary heart disease angiographic trials testing the efficacy of cholesterol lowering in reducing progression or inducing regression of coronary atherosclerosis. Coronary Artery Disease 2(8): 875-879, 1991

Does angiographic regression after cholesterol reduction result in an improved clinical outcome? A meta-analysis of the angiographic coronary regression trials. European Heart Journal 16(ABSTR Suppl. ): 344, 1995

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 91(10): 2528-2540, 1995

Effect of pravastatin (10 mg/day) on progression of coronary atherosclerosis in patients with serum total cholesterol levels from 160 to 220 mg/dl and angiographically documented coronary artery disease. Coronary Artery Regression Study (CARS) Group. American Journal of Cardiology 79(7): 893-896, 1997

Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy. American Journal of Cardiology 105(9): 1289-1296, 2010

Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels. Journal of Cardiopulmonary Rehabilitation 15(6): 445-446, 1995

Prediction of short-term progression or regression of atherosclerotic coronary artery disease by lipoprotein (a): a quantitative coronary angiographic study. Angiology 54(6): 641-646, 2003

Regression of coronary atherosclerosis in patients with coronary artery disease and normal cholesterol, less than 180 mg/dl by aggressive lipid-lowering therapy with pravastatin. Circulation 98(17 Suppl. ): I534, 1998

Regression of coronary atherosclerosis in patients with coronary artery disease and normal cholesterol by intensive lipid-lowering therapy with pravastatin. Circulation 96(8 Suppl. ): I392, 10/21/97, 1997

Comparative meta-analysis of 6 statin and 9 non-statin coronary regression trials Evidence that cholesterol lowering is the key to outcomes. Circulation 94(8 Suppl. ): I579, 1996

Regression and progression of coronary artery disease during lipid lowering treatment. Journal of the American College of Cardiology 21(2 Suppl. A): 70A, 1993

Retardation and arrest of progression or regression of coronary artery disease: a review. Progress in Cardiovascular Diseases 35(6): 435-454, 1993

Modification of coronary artery disease progression by cholesterol-lowering therapy: the angiographic studies. Current Opinion in Lipidology 10(6): 527-534, 1999

A pan-coronary artery angiographic study of the association between diabetes mellitus and progression or regression of coronary atherosclerosis. Heart and Vessels 32(4): 376-384, 2017

Survival prognosis of coronary artery disease in japan progression and regression in angiographic findings. Japanese Journal of Medicine 22(4): 366, 1983